The use of low-dose trazodone in the treatment of painful diabetic neuropathy

Journal of the American Podiatric Medical Association

Volumn 89, Issue 9, 1999, Pages 468-471

  Wilson, Richard C ^a,b,c  

^a American College of Foot and Ankle Surgeons   (United States)

^b Holmes Regional Medical Center   (United States)

^c Melbourne Podiatry Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRAZODONE;

ADULT; AGED; ARTICLE; DIABETIC FOOT; FEMALE; HUMAN; MALE; MIDDLE AGED; PAIN; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; DIABETIC FOOT; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; SEROTONIN UPTAKE INHIBITORS; TRAZODONE; TREATMENT OUTCOME;

EID: 0033193216     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/87507315-89-9-468     Document Type: Article

References (36)

1. ARENSON DJ, SHERWOOD CF, WILSON RC: Neuropathy, angiopathy, and sepsis in the diabetic foot: part one. neuropathy. JAPMA 71: 618, 1981.
2. BROOKS PJ, FRANCISCO GE: Drug therapy of diabetic neuropathy. Clin Podiatr Med Surg 9: 257, 1992.
3. DAVIDSON MB: Diabetes Mellitus: Diagnosis and Treatment, 3rd Ed, Churchill Livingstone, New York, 1991.
4. CAPSAICIN STUDY GROUP: Treatment of painful diabetic neuropathy with topical capsaicin: a multicenter, double-blind, vehicle-controlled study. Arch Intern Med 151: 2225, 1991.
5. CAPSAICIN STUDY GROUP: Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care 15: 159, 1992.
6. ROSS DR, VARIPAPA RJ: Treatment of painful diabetic neuropathy with topical capsaicin. N Engl J Med 321: 475, 1989.
7. VINIK A, HOLLAND M, LEBEAU J: Diabetic neuropathies. Diabetes Care 15: 1926, 1992.
8. HOROWITZ SH: Diabetic control and neuropathy. Ann Intern Med 95: 654, 1981.
9. CHEN KL, HARRIS S: Efficacy with safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Ann Intern Med 147: 1442, 1987.
10. JAMES JS, PAGE JC: Painful diabetic peripheral neuropathy. JAPMA 84: 439, 1994.
11. TAN YM, CROESE J: Clonidine and diabetic patients with leg pains. Ann Intern Med 105: 663, 1986.
12. BELGRADE MJ, LEV BI: Diabetic neuropathy. Postgrad Med 90: 263, 1991.
13. QUATRARO A, MINEI A, DEROSA N, ET AL: Calcitonin in painful diabetic neuropathy. Lancet 339: 746, 1992.
14. SAINATI SM: Pentoxifylline and diabetic neuropathy. Diabetes Care 14: 930, 1991.
15. COHEN SM, MATHEWS T: Pentoxifylline in the treatment of distal diabetic neuropathy. Angiology 42: 741, 1991.
16. JONES CL, GONZALEZ V: Pyridoxine deficiency: a new factor in diabetic neuropathy. JAPA 68: 646, 1978.
17. YAQUB BA, SIDDIQUE A, SULIMANI R: Effects of methyl-cobalamin on diabetic neuropathy. Clin Neurol Neurosurg 94: 105, 1992.
18. KOUTSIKOS S, ARGOYANNIS B, TZANATOS-EXARCHOU H: Biotin for diabetic peripheral neuropathy. Biomed Pharmacother 44: 511, 1990.
19. MCQUAY HJ, MOORE RA: Antidepressants and chronic pain. BMJ 314: 763, 1997.
20. MAX MB, LYNCH SA, MUIR J, ET AL: Effects of desipramine, amitriptylinc, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326: 1250, 1992.
21. PERKINS AT, MORGENLANDER JC: Endocrinologic causes of peripheral neuropathy. Postgrad Med 102: 81, 1997.
22. FABRE LF: United States experience and perspectives with trazodone. Clin Neuropharm 12 (suppl 1): 511, 1989.
23. KHURANA RC: Treatment of painful diabetic neuropathy with trazodone. JAMA 250: 1392, 1983.
24. GUDAS CJ: Prophylactic surgery in the diabetic foot. Clin Podiatr Med Surg 4: 445, 1987.
25. SIMEONE LR, VEVES A: Screening technique to identify the diabetic patient at risk for ulceration. JAPMA 87: 313, 1997.
26. WATKINS PJ: Pain and diabetic neuropathy. BMJ 288: 168, 1984.
27. KAPLAN WE, ABOURIZK NN: Diabetic peripheral neuropathies affecting the lower extremity. JAPA 71: 356, 1981.
28. STAUFFER JD: Antidepressants and chronic pain. J Fam Pract 25: 167, 1987.
29. KVINESDAHL B, MOLIN J, FROLAND A, ET AL: Imipramine treatment of painful diabetic neuropathy. JAMA 251: 1727, 1984.
30. SWIFT CG, HAYTHORNE JM, CLARKE P, ET AL: Cardiovascular, sedative, and anticholinergic effects of amitriptyline and zimelidine in young and elderly volunteers. Acta Psychiatr Scand Suppl 290: 425, 1981.
31. BRYSON HM, WILDE MI: Amitriptyline: a review of its pharmacological properties and therapeutic use in chronic pain states. Drugs Aging 8: 459, 1996.
32. VRETHEM M, BOIVIE J, ARNQVIST H, ET AL: A comparison of amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain 13: 313, 1997.
33. BRYANT SG, FISHER S, KLUGE RM: Long-term versus short-term amitriptyline side effects as measured by a postmarketing surveillance system. J Clin Psychopharmacol 7: 78, 1987.
34. SCHMIDT LG, GROHMANN R, HELMCHEN H, ET AL: Adverse drug reactions: an epidemiological study at psychiatric hospitals. Acta Psychiatr Scand 70: 77, 1984.
35. GERSHON S, NEWTON R: Lack of anticholinergic side effects with a new antidepressant - trazodone. J Clin Psychiatry 41: 100, 1980.
36. RAKEL RE: The greater safety of trazodone over tricyclic antidepressants: 5-year experience in the United States. Psychopathology 20 (suppl 1): 57, 1987.